NIH-funded research Fellowship grant

Understanding how damaged cells contribute to seizures after brain injuries

Official title: Evaluating the contribution of senescent cells in a model of post-traumatic epilepsy

Funded at Georgetown University · NIH-11164408 · Data updated 2026-11-12

This study is looking at how certain damaged cells in the brain might lead to seizures after a head injury, and it hopes to find out if getting rid of these cells can help prevent or lessen those seizures for people who have had a traumatic brain injury.

More Epilepsy research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionGeorgetown University
NIH-funded
Lab location1 site (Washington, United States)
Project startJune 10, 2025
Project endOctober 31, 2029
Funding year2025
Award (this year)$36,838
NIH project number1F30NS143374-01
Project IDNIH-11164408 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have suffered a traumatic brain injury and are at risk of developing post-traumatic epilepsy.

Less likely to help

Patients who have not experienced a traumatic brain injury or those with pre-existing epilepsy may not benefit from this research.

What this research studies

This research investigates the role of senescent cells, which are damaged cells that can cause inflammation and other issues, in the development of post-traumatic epilepsy (PTE) following traumatic brain injury (TBI). By using a rodent model that mimics human brain injuries, the researchers aim to understand how these senescent cells contribute to the onset of seizures. The study will explore whether removing these cells can prevent or reduce the occurrence of seizures in this context. This approach could lead to new treatment strategies for individuals who have suffered a TBI.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that prevent seizures in patients who have experienced traumatic brain injuries.

How similar studies have gone: Previous research has shown that targeting senescent cells can halt the progression of epilepsy in other models, suggesting a promising avenue for this investigation.

Where this research is happening

  • Georgetown University
    Washington, United States
    Active

Researchers

  • Principal investigator: Mcfall, David John — Georgetown University
  • Study coordinator: Mcfall, David John

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.